According to Ziopharm Oncology's latest financial reports the company's current revenue is HK$29.05 Million. In 2017 the company made a revenue of HK$49.64 Million a decrease over the revenue in the year 2016 that were of HK$53.31 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.